The role of additional late PSMA-ligand PET/CT in the differentiation between lymph node metastases and ganglia.

Ian Alberts, Christos Sachpekidis, Lotte Dijkstra, George Prenosil, Eleni Gourni, Silvan Boxler, Tobias Gross, George Thalmann, Kambiz Rahbar, Axel Rominger & Ali Afshar-Oromieh
PURPOSE Differentiating between prostate cancer (PC) lesions and benign structures which exhibit radiotracer uptake in PSMA-ligand PET/CT can be challenging. Additional late imaging has been shown to be a powerful method for the discrimination between PC and non-PC lesions, owing to the increasing tracer uptake of the former. Nevertheless, there are no pre-existing studies which describe the dynamic tracer uptake for ganglia, which this present study aims to address. METHODS Fifty consecutive patients with PC...
This data repository is not currently reporting usage information. For information on how your repository can submit usage information, please see our documentation.